When was BioIntelliSense founded?

BioIntelliSense was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is BioIntelliSense located?

BioIntelliSense is headquartered in Denver, United States. It is registered at Redwood City, California.

Who is the current CEO of BioIntelliSense?

James Mault and David Wang s of BioIntelliSense. James Mault has also founded 1 company.

How many employees does BioIntelliSense have?

As of Mar 31, 2026, the latest employee count at BioIntelliSense is 91.

Is BioIntelliSense a funded company?

BioIntelliSense is a funded company, having raised a total of $140M across 4 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 14, 2018.

When was the latest funding round of BioIntelliSense?

BioIntelliSense's latest funding was a $***** Series C round on Dec 04, 2025, with participation from 0 investor.

Where does BioIntelliSense rank among its competitors?

BioIntelliSense ranks 28th amongst 1087 active competitors, of which 247 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Biobeat, which secured $50M in Dec, 2025.

Who are the top competitors of BioIntelliSense?

BioIntelliSense's top competitors include Withings, Insulet and Masimo. Among them, Biobeat secured the most recent funding round in December, 2025.

BioIntelliSense - 2026 Company Profile, Team, Funding & Competitors

BioIntelliSense is a series C company based in Denver (United States), founded in 2018 by James Mault and David Wang. It operates as a Developer of medical-grade wearable devices and data services for patient monitoring. BioIntelliSense has raised $140M in funding from Chimera. The company has 1087 active competitors, including 247 funded and 67 that have exited. Its top competitors include companies like Withings, Insulet and Masimo.

Company Details

Developer of medical-grade wearable devices and data services for patient monitoring. it provides BioButton a rechargeable, multi-parameter wearable that captures vital signssuch as heart rate, respiratory rate, and skin temperature. It is integrated with data platforms BioCloud that provides advanced analytics and algorithmic notifications to support actionable triage and workflow efficiency and BioDashboard that Enables exception-based management for more proactive clinical decision-making.

Website: biointellisense.com
Social
Email ID: *****@biointellisense.com, *****@biointellisense.com
Phone Number: +1 **********
Registered Address: Redwood City, California

Key Metrics

Founded Year

2018

Location

Denver, United States

Stage

Series C

Total Funding

$140M in 4 rounds

Latest Funding Round

Series C, Dec 04, 2025, $*****

Investors

Chimera & 13 more

Ranked

28^th among 1087 active competitors

Employee Count

91 as on Mar 31, 2026

Investment & Acquisitions

AlertWatch

Similar Companies

Withings & 1235 more

View BioIntelliSense's full profile

BioIntelliSense is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOINTELLISENSE INC CIN: 830671724 , United States, Active	May 22, 2018	-	83 (As on Dec 31, 2024)	-

BioIntelliSense has raised a total funding of $140M over 4 rounds. Its first funding round was on Dec 14, 2018. BioIntelliSense has 12 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of BioIntelliSense:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 04, 2025	8829147	Series C	8106849	7543716	9410030	3738535
Jul 28, 2021	6349453	Series B	9242498	6621939	1756087	7wire Ventures & 8 more
Aug 20, 2020	9599207	Series B	9983000	3243387	4112821	7528580

Access funding benchmarks and valuations. Sign up today!

View details of BioIntelliSense's funding rounds and investors

The founders of BioIntelliSense are James Mault and David Wang. David Wang and James Mault are the CEOs of BioIntelliSense.

Here are the details of BioIntelliSense's key team members:

James Mault: Co-Founder&CEO of BioIntelliSense. They serve on the board of 1 company.
David Wang: CEO of BioIntelliSense.
Contact Info: 1 email address

BioIntelliSense's Board of Directors

BioIntelliSense's board has 9 active members. Lawrence Leisure, Steve Hess, James Mault, Alan Meeker, Larry Leisure, Ronald Chwang, David Wang, James R. Mault and John Driscoll are independent board members.

Here is the list of BioIntelliSense's board of directors:

Name	Type	Representing	Status	Duration
Lawrence Leisure	Independent board member	-	Current	3y 6m
{kuisdr	Independent board member	-	Current	7y 6m
zrcdpq{	Independent board member	-	Current	8y 7m
iiqxrfg	Independent board member	-	Current	1y 3m
uvtgoli	Independent board member	-	Current	1y 3m
rqkxazu	Independent board member	-	Current	3y 2m
jbnnnoz	Independent board member	-	Current	2y 5m
{xg{gap	Independent board member	-	Current	2y 8m
jmiveam	Independent board member	-	Current	3y 9m

View details of BioIntelliSense's Founder profiles and Board Members

BioIntelliSense's employee count trend

BioIntelliSense has 91 employees as of Mar 26. Here is BioIntelliSense's employee count trend over the years:

Employee count trend for BioIntelliSense

Uncover BioIntelliSense's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioIntelliSense include Withings, Insulet and Masimo. Here is the list of Top 10 competitors of BioIntelliSense, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Withings 2008, Moulineaux (France), Acquired	Developer of an array of connected products	$93.8M	Bpifrance, Gilde Healthcare & 8 others	83/100
2nd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	78/100
3rd	Masimo 1989, Irvine (United States), Acquired	Provider of wide range of devices to monitor health parameters	-	Cota Capital, Bank of the West & 8 others	70/100
4th	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	70/100
5th	HyperIce 2011, Irvine (United States), Series C	Internet first brand offering smart devices for physical fitness	$52.5M	MainStreet Advisors, SC.Holdings & 38 others	69/100
6th	Endotronix 2007, East Peoria (United States), Acquired	Provider of device for Measurement of Hemodynamic parameters for heart failure maangement	$155M	Life Sciences Partners, Seroba Life Sciences ... & 14 others	65/100
7th	Sibel Health 2018, Niles (United States), Series C	Developer of wireless medical monitoring devices for clinical and remote use	$71M	Steele Foundation for Hope, JLABS & 5 others	62/100
8th	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Khosla Ventures, Bold Capital Partners & 9 others	60/100
9th	Biobeat 2014, Petah Tikva (Israel), Series B	Body vitals monitoring solution	$51M	Orbimed, Ally Bridge Group & 5 others	60/100
10th	Health Hero Network 1988, London (United Kingdom), Acquired	Offers technology-based solutions for remote health monitoring and management.	$34M	Integral Capital Partners, KSV Global & 7 others	60/100
28th	BioIntelliSense 2018, Denver (United States), Series C	Developer of medical-grade wearable devices and data services for patient monitoring	$140M	Philips, Chimera & 12 others	52/100